Tumor-associated monocyte-derived DCs (MoDCs) possess a suppressive TIP-DC phenotype, preventing T cells from being potently activated by high expression levels of inducible nitric oxide synthase (iNOS) and TNF-α. The gene discussed is NOS2; the disease is neoplasm.